Pulmonary artery pressure in cystic fibrosis adults: Characteristics, clinical correlates and long-term follow-up

Journal of Cystic Fibrosis

Volumn 11, Issue 6, 2012, Pages 532-538

  Bright Thomas, Rowland J ^a   Ray, Simon G ^a   Webb, A Kevin ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

Cystic fibrosis; Doppler echocardiography; Pulmonary artery pressure; Survival

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ARTICLE; BLOOD OXYGEN TENSION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; LONG TERM CARE; LUNG ARTERY PRESSURE; LUNG DISEASE; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; SURVIVAL RATE;

ADULT; COHORT STUDIES; CYSTIC FIBROSIS; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; HYPERTENSION, PULMONARY; MALE; OXIMETRY; OXYGEN; PARTIAL PRESSURE; PREDICTIVE VALUE OF TESTS; SURVIVAL RATE; YOUNG ADULT;

EID: 84869091821     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2012.04.012     Document Type: Article

References (30)

1. Dodge J.A., Lewis P.A., Stanton M., Wilsher J. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J Mar 2007, 29(3):522-526.
2. Siassi B., Moss A.J., Dooley R.R. Clinical recognition of cor pulmonale in cystic fibrosis. J Pediatr 1971, 78(5):794-805.
3. Stern R.C., Borkat G., Hirschfeld S.S., Boat T.F., Matthews L.W., Liebman J., et al. Heart failure in cystic fibrosis. Treatment and prognosis of cor pulmonale with failure of the right side of the heart. Am J Dis Child 1980, 134(3):267-272.
4. Tonelli A.R., Fernandez-Bussy S., Lodhi S., Akindipe O.A., Carrie R.D., Hamilton K., et al. Prevalence of pulmonary hypertension in end-stage cystic fibrosis and correlation with survival. J Heart Lung Transplant Aug 2010, 29(8):865-872.
5. Venuta F., Rendina E.A., Rocca G.D., De Giacomo T., Pugliese F., Ciccone A.M., et al. Pulmonary hemodynamics contribute to indicate priority for lung transplantation in patients with cystic fibrosis. J Thorac Cardiovasc Surg Apr 2000, 119(4):682-689.
6. Fraser K.L., Tullis D.E., Sasson Z., Hyland R.H., Thornley K.S., Hanly P.J. Pulmonary hypertension and cardiac function in adult cystic fibrosis: role of hypoxemia. Chest May 1999, 115(5):1321-1328.
7. Fauroux B., Hart N., Belfar S., Boulé M., Tillous-Borde I., Bonnet D., et al. Burkholderia cepacia is associated with pulmonary hypertension and increased mortality among cystic fibrosis patients. J Clin Microbiol Dec 2004, 42(12):5537-5541.
8. Currie P.J., Seward J.B., Chan K.L., Fyfe D.A., Hagler D.J., Mair D.D., et al. Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients. J Am Coll Cardiol 1985, 6(4):750-756.
9. Yock P.G., Popp R.L. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 1984, 70(4):657-662.
10. Berger M., Haimowitz A., Van Tosh A., Berdoff R.L., Goldberg E. Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. J Am Coll Cardiol 1985, 6(2):359-365.
11. Bossone E., Rubenfire M., Bach D.S., Ricciardi M., Armstrong W.F. Range of tricuspid regurgitation velocity at rest and during exercise in normal adult men: implications for the diagnosis of pulmonary hypertension. J Am Coll Cardiol 1999, 33(6):1662-1666.
12. Aessopos A., Farmakis D., Taktikou H., Loukopoulos D. Doppler-determined peak systolic tricuspid pressure gradient in persons with normal pulmonary function and tricuspid regurgitation. J Am Soc Echocardiogr 2000, 13(7):645-649.
13. McQuillan B.M., Picard M.H., Leavitt M., Weyman A.E. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation 2001, 104(23):2797-2802.
14. Galiè N., Torbicki A., Barst R., Dartevelle P., Haworth S., Higenbottam T., et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension: the Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 2004, 25:2243-2278.
15. Tramarin R., Torbicki A., Marchandise B., Laaban J.P., Morpurgo M. Doppler echocardiographic evaluation of pulmonary artery pressure in chronic obstructive pulmonary disease. A European multicentre study. Working Group on Noninvasive Evaluation of Pulmonary Artery Pressure. European Office of the World Health Organization, Copenhagen. Eur Heart J 1991, 12(2):103-111.
16. Burghuber O.C. Doppler assessment of pulmonary haemodynamics in chronic hypoxic lung disease. Thorax 1996, 51(1):9-12.
17. Marchandise B., De Bruyne B., Delaunois L., Kremer R. Noninvasive prediction of pulmonary hypertension in chronic obstructive pulmonary disease by Doppler echocardiography. Chest 1987, 91(3):361-365.
18. Francis P.W., Muller N.L., Gurwitz D., Milligan D.W., Levison H., Bryan A.C. Hemoglobin desaturation: its occurrence during sleep in patients with cystic fibrosis. Am J Dis Child Aug 1980, 134(8):734-740.
19. Rovedder P.M., Ziegler B., Pasin L.R., Rampon G., Pinotti A.F., de Tarso Roth Dalcin P., et al. Doppler echocardiogram, oxygen saturation and submaximum capacity of exercise in patients with cystic fibrosis. J Cyst Fibros Jul 2007, 6(4):277-283.
20. Ben Tov A., Paret G., Sela B.A., Blau H., Hegesh J., Efrati O., et al. N-terminal pro B-type natriuretic peptide (N-BNP) levels in cystic fibrosis patients. Pediatr Pulmonol Aug 2007, 42(8):699-703.
21. Kerem E., Reisman J., Corey M., Canny G.J., Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med Apr 30 1992, 326(18):1187-1191.
22. Dalen J.E. The pulmonary artery catheter-friend, foe, or accomplice?. JAMA 2001, 286(3):348-350.
23. Naeije R. Pulmonary vascular function. Pulmonary Circulation. A handbook for clinicians 1996, 13-26. Chapman and Hall Medical. A.J. Peacock (Ed.).
24. Laaban J.P., Diebold B., Zelinski R., Lafay M., Raffoul H., Rochemaure J. Noninvasive estimation of systolic pulmonary artery pressure using Doppler echocardiography in patients with chronic obstructive pulmonary disease. Chest 1989, 96(6):1258-1262.
25. Miguéres M., Escamilla R., Coca F., Didier A., Krempf M. Pulsed Doppler echocardiography in the diagnosis of pulmonary hypertension in COPD. Chest 1990, 98(2):280-285.
26. Arcasoy S.M., Christie J.D., Ferrari V.A., Sutton M.S., Zisman D.A., Blumenthal N.P., et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003, 167(5):735-740.
27. Brecker S.J., Gibbs J.S., Fox K.M., Yacoub M.H., Gibson D.G. Comparison of Doppler derived haemodynamic variables and simultaneous high fidelity pressure measurements in severe pulmonary hypertension. Br Heart J 1994, 72(4):384-389.
28. Goldring R.M., Fishman A.P., Turino G.M., Cohen H.I., Denning C.R., Andersen D.H. Pulmonary hypertension and cor pulmonale in cystic fibrosis of the pancreas. J Paediatr 1964, 65:501-524.
29. Henno P., Maurey C., Danel C., Bonnette P., Souilamas R., Stern M., et al. Pulmonary vascular dysfunction in end-stage cystic fibrosis: role of NF-kappaB and endothelin-1. Eur Respir J Dec 2009, 34(6):1329-1337. [Epub 2009 May 21].
30. Fessel J.P., Loyd J.E., Austin E.D. The genetics of pulmonary arterial hypertension in the post-BMPR2 era. Pulm Circ Jul 2011, 1(3):305-319.